Author:
Haferlach T., ,Löffler H.,Gassmann W.,Fonatsch C.,Schoch C.,Haase D.,Schlegelberger B.,Ludwig W.-D.,Thiel E.,Heinecke A.,Sauerland M. C.,Wörmann B.,Hiddemann W.,Büchner Th.
Publisher
Springer Berlin Heidelberg
Reference22 articles.
1. Brito-Babapulle F, Catovsky D, Galton DAG (1987) Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 66: 445–450
2. Jinnai I, Tomonaga M, Kuriyama K, Matsuo T, Nonaka H, Amenomori T, Yoshida Y, Kusano M, Tagawa M, Ichimaru, M (1987) Dysmegakaryocytopoiesis in acute leukaemias: Its predominance in myelomonocytic ( M4) leukaemia and implication for poor response to chemotherapy. Br J Haematol 66: 467–472
3. Estienne MH, Fenaux P, Preudhomme C, Lai JL, Zandecki M, Lepelley P, Cosson A (1990) Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients. Clin lab Haemat 12: 57–65
4. Goasguen JE, Matsuo T, Cox C, Bennett JM (1992) Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: Major importance of dysgranulopoiesis for remission and survival. Leukemia 6: 520–525
5. Goasguen JE, Büchner T, Hiddemann W, Wörmann B, Heinecke A, Sauerland MC, Fonatsch C, Becher R, Hossfeld D, Löffler H, Schaefer UW (1993) Prognostic importance of myeloid dysplastic features in AML. Blood 82 Suppl 1: 124